ClinicalTrials.gg
Not yet recruitingNCT07947238Updated Nov 18, 2026

Cortical Oxygenation and Serve Speed in Female Volleyball Players

An observational study in Near-Infrared Spectroscopy, Volleyball and Prefrontal Cortex, sponsored by Istinye University. Not yet recruiting. Open to female participants aged 17 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Istinye University · Observational

How we know

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
34
Ages
17 Years to 21 Years
Sex
Female
01

Study summary

34 volunteer professional female volleyball players (aged 17-21), licensed in the Turkish Volleyball Federation (TVF) Women's Volleyball League 2 and 3, will be included in the study. No intervention will be applied. All participants will be assessed in a single session, in which cortical oxygenation of the prefrontal, premotor and motor cortex will be measured with a wireless fNIRS device and serve speed will be measured with a radar gun simultaneously during the volleyball serve.

Read the detailed description

34 professional female volleyball players licensed in the TVF Women's Volleyball League 2 and League 3, aged 17-21 years, with at least three years of regular training and competition experience, will be included using purposive sampling. Sample size was determined using G*Power 3.1 software (correlation: point biserial model, one-tailed) with 80% power, 0.05 type-1 error and an effect size of 0.40, giving a minimum of 34 participants. All participants will be assessed in a single session at the Istinye University Physiotherapy and Rehabilitation Application and Research Center (ISUFIZYOTEM). After a standardized 15-minute warm-up and placement of the fNIRS headset, each participant will perform five successful serves with 60 seconds of rest between serves, using the serve type they use most often in competition. Cortical oxygenation and serve speed will be recorded simultaneously for each serve. Measurements will be scheduled at least 24 hours after the last official match or high-intensity training session. Primary assessments include changes in oxyhemoglobin and deoxyhemoglobin in the prefrontal, premotor and motor cortex during the serve, measured with a wireless fNIRS device; serve speed, defined as the highest speed (km/h) of five successful serves and measured with a Bushnell Velocity Speed Gun radar; and demographic and anthropometric data, including age, height, body weight, body mass index, years of training, weekly training frequency, playing position and serve type.

02

Conditions studied

  • Near-Infrared Spectroscopy
  • Volleyball
  • Prefrontal Cortex

Keywords

  • fNIRS
  • Near-Infrared Spectroscopy
  • Prefrontal Cortex
  • Serve Speed
  • Female Athletes
03

In context

Lead sponsor

Istinye University is the lead sponsor of 224 studies on the registry; 96 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 21 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Female volleyball players aged 17-21 years who hold an active license with Unsped Culture and Sports Club and compete in the Turkish Volleyball Federation (TVF) Women's 2nd and 3rd Leagues. Participants play as setter, outside hitter, opposite or middle blocker (liberos are excluded because they do not serve) and have at least three years of regular volleyball training and official competition experience. Players with musculoskeletal surgery in the last six months, current pain or acute injury affecting serving, or a neurological, vestibular, cognitive, cardiovascular, respiratory or metabolic condition limiting physical activity are excluded. Participants are recruited through the club and assessed in a single session at the Istinye University Physiotherapy and Rehabilitation Application and Research Center (ISUFIZYOTEM).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Holding an active license in the Turkish Volleyball Federation (TVF) Women's Volleyball League 2 or League 3 and participating in official competitions at the professional level.
  • Having at least three years of regular volleyball training and official competition experience.
  • Having the functional capacity to perform the serve independently, without pain, and in accordance with competition rules.

Exclusion criteria

Exclusion Criteria:

  • Having undergone any musculoskeletal surgery within the last six months.
  • Presence of musculoskeletal pain, acute injury or functional loss that may affect serve performance prior to the assessment or testing procedures.
  • Having a diagnosed disease affecting neurological, vestibular or cognitive functions that may impair assessment results and sports performance.
  • Participation in moderate- to high-intensity physical activity being medically due to cardiovascular, respiratory, metabolic or systemic disease.
  • Concurrently participating in an additional rehabilitation program, neuromodulation application or experimental performance-enhancement study during the research period.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
34 participants (estimated)
Patient registry
No

Groups and cohorts

  • Female Volleyball Players

    In this study, the primary aim is to examine the correlation between serve speed and cortical oxygenation. The secondary aim is to examine differences in serve speed and cortical oxygenation between playing positions. Therefore, no separate groups are defined; all participants are analyzed as a single sample. No intervention is applied.

06

What researchers measure

Primary outcomes

  1. Cortical Oxygenation Measured by Functional Near-Infrared Spectroscopy

    Changes in oxyhemoglobin and deoxyhemoglobin concentrations in the prefrontal, premotor and motor cortex during the volleyball serve will be measured with a wireless functional near-infrared spectroscopy (fNIRS) device. fNIRS is a non-invasive, portable neuroimaging method that indirectly assesses neural activation by measuring hemodynamic changes in the cortex through optical sensors placed on the head. The sensors will be positioned over the prefrontal, premotor and motor cortex, and cortical oxygenation changes will be recorded in real time. Each task will be repeated three times to ensure intra-subject reliability, and sensor signals will be checked after each repetition, with calibration performed if necessary.

    Time frame: Baseline

  2. Serve speed

    Serve speed (km/h) will be measured with a Bushnell 1101911 Velocity Speed Gun radar. The device will be placed on a fixed tripod 5 meters from the net, parallel to the service line, and focused on the line where the ball passes at a height of approximately 1.5 meters, ensuring correct intersection of the radar beam with the ball. Each participant will perform five successful serves in accordance with competition rules, with a serve considered successful if the ball crosses the net and lands within the court. Sixty seconds of rest will be given between serves, and device calibration will be checked after each serve to minimize measurement errors. The highest recorded serve speed for each participant will be used as the performance indicator. All measurements will be performed under similar temperature and humidity conditions.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Altundag E, Soylu C, Akyildiz Z. Multidimensional analysis of serving speed in volleyball players by position, sets, and league types: interactions and statistical differences. BMC Sports Sci Med Rehabil. 2024 Dec 6;16(1):240. doi: 10.1186/s13102-024-01031-z. PubMed 39643912 ↗
  • Herold F, Wiegel P, Scholkmann F, Muller NG. Applications of Functional Near-Infrared Spectroscopy (fNIRS) Neuroimaging in Exercise(-)Cognition Science: A Systematic, Methodology-Focused Review. J Clin Med. 2018 Nov 22;7(12):466. doi: 10.3390/jcm7120466. PubMed 30469482 ↗
  • Trecroci A, Duca M, Cavaggioni L, Rossi A, Scurati R, Longo S, Merati G, Alberti G, Formenti D. Relationship between Cognitive Functions and Sport-Specific Physical Performance in Youth Volleyball Players. Brain Sci. 2021 Feb 12;11(2):227. doi: 10.3390/brainsci11020227. PubMed 33673260 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 18, 2026
StartEst.
Nov 20, 2026
Primary completionEst.
Dec 30, 2026
CompletionEst.
Feb 20, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07947238
Lead sponsor
Istinye University
Responsible party
İlimdar Taştanoğlu (PT, Istinye University) — Principal investigator
First posted
Nov 18, 2026
Start date
Nov 20, 2026 (estimated)
Primary completion
Dec 30, 2026 (estimated)
Completion
Feb 20, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

İlimdar Taştanoğlu
Contact
fztilimdar@gmail.com
+905427674299
Gül Deniz Yılmaz Yelvar
study director · Istinye University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion